BNT115 / BioNTech - LARVOL DELTA

OLIVIA: Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy (clinicaltrials.gov) - P1 | N=8 | Terminated | Sponsor: University Medical Center Groningen | Trial completion date: Dec 2023 ➔ Jun 2023 | Active, not recruiting ➔ Terminated | Trial primary completion date: Feb 2023 ➔ Jun 2023; Despite the extension of the original recruitment period, the target number of evaluable patients defined in the study protocol could not be reached and recruitment for the trial was stopped at that point of time.

Combination therapy • Trial completion date • Trial primary completion date • Trial termination • Oncology • Ovarian Cancer • Solid Tumor • CD8

OLIVIA: Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy (clinicaltrials.gov) - P1 | N=10 | Active, not recruiting | Sponsor: University Medical Center Groningen | Recruiting ➔ Active, not recruiting

Combination therapy • Enrollment closed • Oncology • Ovarian Cancer • Solid Tumor • CD8